BR100 Decreased By (-1.08%)
BR30 Decreased By (-1.23%)
KSE100 Decreased By (-0.85%)
KSE30 Decreased By (-1.61%)
AGHA 6.11 Decreased By ▼ -0.07 (-1.13%)
BECO 4.12 Decreased By ▼ -0.11 (-2.6%)
BML 61.59 Decreased By ▼ -0.25 (-0.4%)
BOP 30.94 Decreased By ▼ -0.76 (-2.4%)
CNERGY 12.10 Increased By ▲ 0.04 (0.33%)
CSIL 5.65 Increased By ▲ 0.02 (0.36%)
FCCL 58.05 Decreased By ▼ -0.66 (-1.12%)
FFL 13.35 Decreased By ▼ -0.12 (-0.89%)
FNEL 1.16 Decreased By ▼ -0.01 (-0.85%)
KEL 6.11 Decreased By ▼ -0.03 (-0.49%)
KOSM 5.61 Decreased By ▼ -0.05 (-0.88%)
LOTCHEM 24.43 Decreased By ▼ -0.39 (-1.57%)
MLCF 100.04 Decreased By ▼ -2.05 (-2.01%)
NBP 175.92 Decreased By ▼ -3.74 (-2.08%)
NCPL 51.73 Increased By ▲ 1.68 (3.36%)
NPL 53.95 Increased By ▲ 1.05 (1.98%)
OGDC 312.89 Decreased By ▼ -3.35 (-1.06%)
PACE 9.22 Increased By ▲ 0.01 (0.11%)
PAEL 33.48 Decreased By ▼ -0.54 (-1.59%)
PIBTL 13.19 Decreased By ▼ -0.23 (-1.71%)
PPL 217.96 Decreased By ▼ -3.34 (-1.51%)
PRL 85.55 Increased By ▲ 0.95 (1.12%)
PTC 47.64 Decreased By ▼ -0.74 (-1.53%)
SSGC 22.60 Decreased By ▼ -0.34 (-1.48%)
TBL 9.16 Decreased By ▼ -0.14 (-1.51%)
TELE 7.15 Increased By ▲ 0.08 (1.13%)
TPL 25.48 Decreased By ▼ -0.38 (-1.47%)
TPLP 13.36 Increased By ▲ 0.25 (1.91%)
TREET 24.56 Decreased By ▼ -0.43 (-1.72%)
TRG 53.41 Decreased By ▼ -0.62 (-1.15%)
World

UK says Astrazeneca vaccine prevents COVID-19 death as South Africa halts shots

  • "There is no evidence that this vaccine is not effective in preventing hospitalisation and severe illness and death, which ultimately is what we're seeking with these vaccines today," Britain's Edward Argar told Sky.
Published Updated
By

LONDON: There is no evidence that the Astrazeneca vaccine does not prevent death or serious illness, and South Africa has only imposed a temporary halt on using the vaccine, a British junior health minister said on Monday.

South Africa will put on hold use of AstraZeneca's COVID-19 shot in its vaccination programme after data showed it gave minimal protection against mild-to-moderate infection caused by the country's dominant coronavirus variant.

"There is no evidence that this vaccine is not effective in preventing hospitalisation and severe illness and death, which ultimately is what we're seeking with these vaccines today," Britain's Edward Argar told Sky.

"The dominant strains in this country are not the South African strain, there are a small number of cases of that, the dominant strains here are the historic one we've had, and then the Kent variant, against which this vaccine is highly effective."

Comments

Comments are closed for this article.